Analysis of perimenstrual asthma based on questionnaire surveys in Japan

Allergology International

Volumn 56, Issue 3, 2007, Pages 249-255

  Suzuki, Kazuo ^a   Hasegawa, Takashi ^b   Sakagami, Takuro ^a   Koya, Toshiyuki ^a   Toyabe, Shinichi ^b   Akazawa, Kohei ^b   Arakawa, Masaaki ^a   Gejyo, Fumitake ^a   Suzuki, Eiichi ^b  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

Author keywords

Aspirin intolerant asthma; Perimenstrual asthma; Questionnaire survey

Indexed keywords

ACETYLSALICYLIC ACID; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LONG ACTING DRUG; SALMETEROL; THEOPHYLLINE;

ADULT; ALLERGIC ASTHMA; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DAILY LIFE ACTIVITY; DISEASE CONTROL; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG TOLERABILITY; DRUG UTILIZATION; EMERGENCY CARE; FEMALE; HEALTH SURVEY; HUMAN; INCIDENCE; JAPAN; MAJOR CLINICAL STUDY; MENSTRUATION; PATIENT SATISFACTION; PERIMENSTRUAL ASTHMA; PRIORITY JOURNAL; QUESTIONNAIRE; SELF REPORT;

EID: 34548849742     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.O-06-475     Document Type: Article

References (35)

1. Frank RT. The hormonal cause of premenstrual tension. Arch. Neurol. Psychiatry 1931;26:1053-1057.
2. Rees L. An aetiological study of premenstrual asthma. J. Psychosom. Res. 1963;7:191-197.
3. Wulfsohn NL, Politzer WM. Bronchial asthma during menses and pregnancy. S. Afr. Med. J 1964;38:173.
4. Pauli BD, Reid RL, Munt PW, Wigle RD, Forkert L. Influence of the menstrual cycle on airway function in asthmatic and normal subjects. Am. Rev. Respir. Dis. 1989; 140:358-362.
5. Faas M, Bouman A, Moesa H, Heineman MJ, de Leij L, Schuiling G. The immune response during the luteal phase of the ovarian cycle: a Th2-type response? Fertil. Steril. 2000;74:1008-1013.
6. Tan KS. Premenstrual asthma: epidemiology, pathogenesis and treatment. Drugs 2001;61:2079-2086.
7. Hanley SP. Asthma variation with menstruation. Br. J. Dis. Chest 1981;75:306-308.
8. Shames RS, Heilbron DC, Janson SL, Kishiyama JL, Au DS, Adelman DC. Clinical differences among women with and without self-reported perimenstrual asthma. Ann. Allergy Asthma Immunol. 1998;81:65-72.
9. Agarwal AK, Shah A. Menstrual-linked asthma. J. Asthma 1997;34:539-545.
10. Juniper EF, Kline PA, Roberts RS, Hargreave FE, Daniel EE. Airway responsiveness to methacholine during the natural menstrual cycle and the effect of oral contraceptives. Am. Rev. Respir. Dis. 1987;135:1039-1042.
11. Forbes L, Jarvis D, Bumey P. Is pre-menstrual asthma related to the use of aspirin or non-steroidal anti-inflammatory drugs? Respir. Med. 2000;94:828-829.
12. Chandler MH, Schuldheisz S, Phillips BA, Muse KN. Premenstrual asthma: the effect of estrogen on symptoms, pulmonary function, and beta 2-receptors. Pharmacotherapy 1997;17:224-234.
13. Weinmann GG, Zacur H, Fish JE. Absence of changes in airway responsiveness during the menstrual cycle. J. Allergy Clin. Immunol. 1987;79:634-638.
14. Tan KS, McFarlane LC, Lipworth BJ. Modulation of airway reactivity and peak flow variability in asthmatics receiving the oral contraceptive pill. Am. J. Respir. Crit. Care Med. 1997;155:1273-1277.
15. Tan KS, McFarlane LC, Lipworth BJ. Loss of normal cyclical beta 2 adrenoceptor regulation and increased premenstrual responsiveness to adenosine monophosphate in stable female asthmatic patients. Thorax 1997;52:608-611.
16. Eliasson O, Densmore MJ, Scherzer HH, DeGraff AC Jr. The effect of sodium meclofenamate in premenstrual asthma: a controlled clinical trial. J. Allergy Clin. Immunol. 1987;79:909-918.
17. Suzuki E, Hasegawa T, Koya T et al. Questionnaire-based Analysis of Current Status of Adult Bronchial Asthma in Niigata Prefecture. Comparison with the Asthma Guideline. Acta Medica. Biologica. 2002;50:135- 143.
18. Suzuki E, Hasegawa T, Koya T et al. Questionnaire-based Characterization of Bronchial Asthma in Elderly. Analysis in Niigata Prefecture, Japan. Allergol. Int. 2002;51:241-248.
19. Yoshimine F, Hasegawa T, Suzuki E et al. Contribution of Aspirin Intolerant Asthma to Near Fatal Asthma Based on Questionnaire Surveys in Niigata Prefecture, Japan. Respirology 2005;10:477-484.
20. Satoh H, Hasegawa T, Suzuki E et al. Gender Differences in Susceptibility of Asthma to Active Smoking. Questionnaire Based Analysis in the Niigata Prefecture, Japan. Allergol. Int. 2005;54:401-410.
21. Hasegawa T, Suzuki E, Muramatsu Y et al. Questionnaire-based analysis of the current level of asthma control and management in Niigata Prefecture, Japan: Changes from 1998 to 2000. Allergol. Int. 2004;53:135-144.
22. Hasegawa T, Suzuki E, Terada M et al. Improvement of Asthma Management in Actual Practice Consistent with Prevalence of Anti-inflammatory Agents. - Based on Questionnaire Surveys in Niigata Prefecture, Japan from 1998 to 2002 -. Allergol. Int. 2005;54:555-563.
23. Gibbs CJ, Courts II, Lock R, Finnegan OC, White RJ. Premenstrual exacerbation of asthma. Thorax 1984;39:833-836.
24. Eliasson O, Scherzer HH, DeGraff AC Jr. Morbidity in asthma in relation to the menstrual cycle. J. Allergy Clin. Immunol. 1986;77:87-94.
25. Nakasato H, Ohrui T, Sekizawa K et al. Prevention of severe premenstrual asthma attacks by leukotriene receptor antagonist. J. Allergy Clin. Immunol. 1999;104:585-588.
26. Peters SP, MacGlashan DW Jr, Schleimer RP, Hayes EC, Adkinson NF Jr, Lichtenstein LM. The pharmocologic modulation of the release of arachidonic acid metabolites from purified human lung mast cells. Am. Rev. Respir. Dis. 1985;132:367-373.
27. Eliasson O, Scherzer HH. Recurrent respiratory failure in premenstrual asthma. Conn. Med. 1984;48:777-778.
28. Murray RD, New JP, Barber PV, Shalet SM. Gonadotrophin-releasing hormone analogues: a novel treatment for premenstrual asthma. Eur. Respir. J. 1999; 14:966-967.
29. Skobeloff EM, Spivey WH, Silverman R, Eskin BA, Harchelroad F, Alessi TV. The effect of the menstrual cycle on asthma presentations in the emergency department. Arch. Intern. Med. 1996;156:1837-1840.
30. Prescott E, Lange P, Vestbo J. Effect of gender on hospital admissions for asthma and prevalence of self-reported asthma: a prospective study based on a sample of the general population. Copenhagen City Heart Study Group. Thorax 1997;52:287-289.
31. Skobeloff EM, Spivey WH, St. Clair SS, Schoffstall JM. The influence of age and sex on asthma admissions. JAMA 1992;268:3437-3440.
32. Babu KS, Salvi SS. Aspirin and asthma. Chest 2000;118: 1470-1476.
33. Szczeklik A, Stevenson DD. Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management. J. Allergy Clin. Immunol. 2003;111:913-921.
34. Obase Y, Shimoda T, Tomari SY et al. Effects of pranlukast on chemical mediators in induced sputum on provocation tests in atopic and aspirin-intolerant asthmatic patients. Chest 2002;121:143-150.
35. Obase Y, Shimoda T, Tomari S et al. Effects of pranlukast on aspirin-induced bronchoconstriction: differences in chemical mediators between aspirin-intolerant and tolerant asthmatic patients. Ann. Allergy Asthma Immunol. 2001;87:74-79.